These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 1121374

  • 1. Luteinizing hormone, adrenal androgenesis, and polycystic ovarian disease.
    Polansky S.
    Obstet Gynecol; 1975 Apr; 45(4):451-4. PubMed ID: 1121374
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis of polycystic ovarian disease.
    James R, Givens MD.
    Acta Eur Fertil; 1979 Sep; 10(3):89-103. PubMed ID: 121017
    [No Abstract] [Full Text] [Related]

  • 3. The androgenic polycystic ovary.
    Greenblatt RB, Mahesh VB.
    Am J Obstet Gynecol; 1976 Jul 01; 125(5):712-26. PubMed ID: 180807
    [Abstract] [Full Text] [Related]

  • 4. Inappropriate secretion of LH in the Stein-Leventhal syndrome.
    Gambrell RD, Greenblatt RB, Mahesh VB.
    Obstet Gynecol; 1973 Sep 01; 42(3):429-40. PubMed ID: 4724412
    [No Abstract] [Full Text] [Related]

  • 5. Hirsutism and hyperandrogenism.
    Givens JR.
    Adv Intern Med; 1976 Sep 01; 21():221-47. PubMed ID: 130060
    [No Abstract] [Full Text] [Related]

  • 6. Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.
    Givens JR, Andersen RN, Wiser WL, Fish SA.
    J Clin Endocrinol Metab; 1974 May 01; 38(5):727-35. PubMed ID: 4823918
    [No Abstract] [Full Text] [Related]

  • 7. [Proceedings: Rapid HCG test. 2. Chronological changes of blood LH, FSH, T (testosterone), E(estrogen) and DHEA(dehydroepiandrosterone) values after administration of 10,000 units of H.C.G].
    Nita H, Fujita M, Aoyama T, Maruyama H, Kumamoto E.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):316. PubMed ID: 4281389
    [No Abstract] [Full Text] [Related]

  • 8. Effect of spironolactone on testosterone and LHRH responsiveness in women with polycystic ovarian disease.
    Evron S, Yosef SM, Schenker JG, Diamant YZ.
    Isr J Med Sci; 1984 Jul 20; 20(7):630-3. PubMed ID: 6432730
    [No Abstract] [Full Text] [Related]

  • 9. Evidence for the hypothalamic origin of the polycystic ovary syndrome.
    Wortsman J, Singh KB, Murphy J.
    Obstet Gynecol; 1981 Aug 20; 58(2):137-41. PubMed ID: 6454866
    [Abstract] [Full Text] [Related]

  • 10. Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism.
    Pugeat M, Forest MG, Nisula BC, Corniau J, De Peretti E, Tourniaire J.
    Obstet Gynecol; 1982 Jan 20; 59(1):46-51. PubMed ID: 6804896
    [Abstract] [Full Text] [Related]

  • 11. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV, Austin CW, Carlson IH, Kuzma DL, Zweibel WJ.
    Obstet Gynecol; 1985 Feb 20; 65(2):199-205. PubMed ID: 3155830
    [Abstract] [Full Text] [Related]

  • 12. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
    Beck WW, McEvoy D, Wallach EE.
    Obstet Gynecol; 1971 Feb 20; 37(2):211-7. PubMed ID: 5539356
    [No Abstract] [Full Text] [Related]

  • 13. Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion.
    Allon MA, Leach RE, Dunbar J, Diamond MP.
    Fertil Steril; 2005 Apr 20; 83 Suppl 1():1319-26. PubMed ID: 15831308
    [Abstract] [Full Text] [Related]

  • 14. A gonadotropin-responsive adrenocortical adenoma.
    Givens JR, Andersen RN, Wiser WL, Coleman SA, Fish SA.
    J Clin Endocrinol Metab; 1974 Jan 20; 38(1):126-33. PubMed ID: 4358642
    [No Abstract] [Full Text] [Related]

  • 15. Steroid hormone formation in the human ovary. IV. Ovarian stromal compartment; formation of radioactive steroids from acetate-1-14C and action of gonadotropins.
    Rice BF, Savard K.
    J Clin Endocrinol Metab; 1966 Jun 20; 26(6):593-609. PubMed ID: 5913149
    [No Abstract] [Full Text] [Related]

  • 16. Diagnosis of a supernumerary ovary with human chorionic gonadotropin.
    Kosasa TS, Griffiths CT, Shane JM, Leventhal JM, Naftolin F.
    Obstet Gynecol; 1976 Feb 20; 47(2):236-7. PubMed ID: 1250550
    [Abstract] [Full Text] [Related]

  • 17. Serum gonadotropin levels and ancillary studies in Stein-Leventhal syndrome treated with clomiphene citrate.
    Gambrell RD, Greenblatt RB, Mahesh VB.
    Obstet Gynecol; 1971 Dec 20; 38(6):850-62. PubMed ID: 5125433
    [No Abstract] [Full Text] [Related]

  • 18. Primary amenorrhoea associated with polycystic ovarian syndrome.
    Valkov IM, Dokumov SI.
    Reproduccion; 1981 Dec 20; 5(2):119-26. PubMed ID: 6790313
    [Abstract] [Full Text] [Related]

  • 19. [Endocrine effects of laser vaporization of the ovaries in women with polycystic ovary syndrome].
    Rossmanith WG, Keckstein J, Spatzier K, Lauritzen C.
    Gynakol Rundsch; 1991 Dec 20; 31 Suppl 2():333-5. PubMed ID: 1790971
    [No Abstract] [Full Text] [Related]

  • 20. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary.
    Venturoli S, Paradisi R, Fabbri R, Magrini O, Porcu E, Flamigni C.
    Obstet Gynecol; 1984 Jan 20; 63(1):6-11. PubMed ID: 6419189
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.